Fulgent Genetics, Inc. (FLGT) EPS Estimated At $-0.03; SANBIO COMPANY LTD JAPAN (SNBIF) Sellers Increased By 12.6% Their Shorts

February 15, 2018 - By Linda Rogers

Analysts expect Fulgent Genetics, Inc. (NASDAQ:FLGT) to report $-0.03 EPS on February, 26.They anticipate $0.08 EPS change or 160.00% from last quarter’s $0.05 EPS. After having $-0.05 EPS previously, Fulgent Genetics, Inc.’s analysts see -40.00% EPS growth. The stock increased 2.17% or $0.1 during the last trading session, reaching $4.71. About 7,568 shares traded. Fulgent Genetics, Inc. (NASDAQ:FLGT) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

SANBIO COMPANY LTD JAPAN (OTCMKTS:SNBIF) had an increase of 12.6% in short interest. SNBIF’s SI was 88,500 shares in February as released by FINRA. Its up 12.6% from 78,600 shares previously. With 2,900 avg volume, 31 days are for SANBIO COMPANY LTD JAPAN (OTCMKTS:SNBIF)’s short sellers to cover SNBIF’s short positions. It closed at $30.75 lastly. It is down 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

SanBio Company Limited develops regenerative cell medicines for central nervous system. The company has market cap of $1.43 billion. It develops SB623, a therapeutic product for various stroke patients. It currently has negative earnings.

Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. The company has market cap of $83.95 million. The company's technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. It currently has negative earnings. It primarily serves hospitals and medical institutions.

Among 2 analysts covering Fulgent Genetics (NASDAQ:FLGT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Fulgent Genetics had 2 analyst reports since October 24, 2016 according to SRatingsIntel. The stock of Fulgent Genetics, Inc. (NASDAQ:FLGT) earned “Outperform” rating by Credit Suisse on Monday, October 24. As per Monday, October 24, the company rating was initiated by Piper Jaffray.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>